Table 5.

The estimated prevalence (and SE) of FBE in males and females, and founders and nonfounders under Mendelian dominant transmission

FounderNonfounderMean
A. No polygenic component
    Male0.24% (0.01%)0.96% (0.05%)0.60% (0.03%)
    Female0.07% (0.005%)0.30% (0.02%)0.19% (0.01%)
    Mean0.14% (0.01%)0.55% (0.03%)
B. Three polygenic loci
    Male0.21% (0.02%)0.71% (0.04%)0.48% (0.03%)
    Female0.06% (0.01%)0.21% (0.02%)0.14% (0.01%)
    Mean0.12% (0.01%)0.40% (0.03%)